Investors

Curious to learn more about Procavea?

We are driven by the goal of improving human health through innovative protein technologies.

Our proprietary protein-based molecular delivery platform stems from 6 years of focused research at the ETH Zurich. Procavea will leverage this unique technology to overcome current challenges in the delivery of RNA therapeutics. Our award-winning team is now looking for seed investment and support to push the science forward and build upon our founding team. If you’d like to be part of the journey, please get in touch:

team@procavea.com